Jose Abrigo, Esq., HIV Project Director of the Lambda Legal Defense and Education Fund explains the biggest HIV issues anticipated this year.

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will ...

Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes ...

Republicans are fuming at the State Department after learning that recipients of funding from the legacy program to curb ...

Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy.

Terms of the deal were not disclosed in the case, which involved the government’s patents on Gilead’s HIV drugs Truvada and ...

ADDIS ABABA, Ethiopia and KINSHASA, Democratic Republic of the Congo and WASHINGTON and PARIS, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Africa CDC’s ...

Gilead Sciences (GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

For the second year in a row, the CDC’s annual STI report showed an overall decline in combined cases of the three nationally ...

M ore than three years have passed since federal health officials arrived in central Appalachia to assess an alarming ...

The Centers for Disease Control and Prevention has awarded a $1.4 million grant to a University of Albany professor, Melonie ...